Pfizer Inc. PFE, the world's largest research-based
pharmaceutical company, and Zhejiang Hisun Pharmaceuticals (SSE Code:
600267), a leading Chinese pharmaceutical company, today announced the
launch of Hisun-Pfizer Pharmaceuticals Co., Ltd. (hereafter referred to
as Hisun-Pfizer), a joint venture formed between the two companies to
develop, manufacture and commercialize off-patent pharmaceutical
products in China and global markets. The creation of the joint venture
marks an important milestone in strengthening the ability of both
companies to reach more patients with high-quality and low-cost
medicines in the branded generics arena.
The launch ceremony held today was attended by Mr. Shao Zhanwei, Mayor
of the Hangzhou Municipal Government; Mr. Bai Hua, Chairman and
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in